Respiratory depression – pipeline review, h2 2012


Published on

2012 | || Respiratory depression – pipeline review, h2 2012

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Respiratory depression – pipeline review, h2 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Respiratory Depression – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Respiratory Depression - Pipeline Review, H2 2012,provides an overview of the indication’s therapeutic pipeline. This report providesinformation on the therapeutic development for Respiratory Depression, completewith latest updates, and special features on late-stage and discontinued projects. Italso reviews key players involved in the therapeutic development for RespiratoryDepression. Respiratory Depression - Pipeline Review, Half Year is built using dataand information sourced from Global Markets Direct’s proprietary databases,Company/University websites, SEC filings, investor presentations and featuredpress releases from company/university sites and industry-specific third partysources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Respiratory Depression.- A review of the Respiratory Depression products under development bycompanies and universities/research institutes based on information derived from
  2. 2. company and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Respiratory Depression.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Respiratory Depression Overview 6Therapeutics Development 7An Overview of Pipeline Products for Respiratory Depression 7Respiratory Depression Therapeutics under Development by Companies 9Late Stage Products 10Comparative Analysis 10Mid Clinical Stage Products 11Comparative Analysis 11Discovery and Pre-Clinical Stage Products 12Comparative Analysis 12Respiratory Depression Therapeutics – Products under Development by Companies13Companies Involved in Respiratory Depression Therapeutics Development 14Cortex Pharmaceuticals, Inc. 14Galleon Pharmaceuticals 15Sihuan Pharmaceutical Holdings Group Ltd. 16Respiratory Depression – Therapeutics Assessment 17Assessment by Monotherapy Products 17
  3. 3. Assessment by Route of Administration 18Assessment by Molecule Type 20Drug Profiles 22List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012 Review, H22012&PubId=&pagenum=1Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012Respiratory Depression – Pipeline Review, H2 2012Metastatic Cancer – Pipeline Review, H2 2012Viral Infections – Pipeline Review, H2 2012Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
  4. 4. H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: